https://www.selleckchem.com/products/lxh254.html
No differences were observed between educational levels in decisional conflict, confidence in the decision, anxiety and worry about breast cancer, in the intervention and control groups. CONCLUSIONS A decision aid for breast cancer screening had much more impact on informed choice among women with a high educational level. In women with low educational level, the attitude towards screening improved and there was an increase in the intention to be screened. BACKGROUND Olaparib was approved on December 19, 2014 by the US FDA as 4th-line th
Curtir
Comentario
Compartilhar
